Practical guide to prevention of contrast-induced acute kidney injury after percutaneous coronary intervention.
Giulia BuganiFrancesco PonticelliFrancesco GianniniFrancesco GalloEleonora GaudenziAlessandra LaricchiaAndrea FisicaroPaolo CimagliaAntonio MangieriIlja GardiAntonio ColomboPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
Contrast-induced acute kidney injury (CI-AKI) represents a common but serious complication of percutaneous coronary interventions (PCI)-and in general of all those examinations requiring iodinated contrast injection-which affects not only renal function but also long-term prognosis. While several prophylactic approaches were designed in order to prevent CI-AKI, most failed to demonstrate clear benefits in randomized trials, and their implementation is therefore discouraged in clinical practice. The most notorious examples include pre-procedural bicarbonate or N-acetylcysteine, and preprocedural withdrawal of ACE inhibitors/Angiotensin receptor blockers. Those strategies that were instead demonstrated effective include the appropriate use of preprocedural hydration, reduction in contrast volume utilization, adoption of techniques for zero- or ultra-low-contrast procedures, and pharmacological treatments with statins. In this brief review, we summarize the main preventive strategies into brief and pragmatic recommendations designed to improve everyday clinical practice.
Keyphrases
- acute kidney injury
- clinical practice
- magnetic resonance
- percutaneous coronary intervention
- cardiac surgery
- coronary artery disease
- contrast enhanced
- high glucose
- angiotensin converting enzyme
- acute coronary syndrome
- acute myocardial infarction
- healthcare
- st segment elevation myocardial infarction
- angiotensin ii
- cardiovascular disease
- diabetic rats
- primary care
- coronary artery
- physical activity
- st elevation myocardial infarction
- atrial fibrillation
- antiplatelet therapy
- type diabetes
- minimally invasive
- endothelial cells
- high resolution
- randomized controlled trial
- mass spectrometry
- aortic stenosis
- ejection fraction